Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

C. Male; A.W.A. Lensing; J.S. Palumbo; R. Kumar; I. Nurmeev; K. Hege; D. Bonnet; P. Connor; H.L. Hooimeijer; M. Torres; A.K.C. Chan; G. Kenet; S. Holzhauer; A. Santamaria; P. Amedro; E. Chalmers; P. Simioni; R.V. Bhat; D.L. Yee; O. Lvova; J. Beyer-Westendorf; T.T. Biss; I. Martinelli; P. Saracco; M. Peters; K. Kallay; C.A. Gauger; M.P. Massicotte; G. Young; A.F. Pap; M. Majumder; W.T. Smith; J.F. Heubach; S.D. Berkowitz; K. Thelen; D. Kubitza; M. Crowther; M.H. Prins; P. Monagle; EINSTEIN-Jr Phase 3 Investigators

doi:10.1016/S2352-3026(19)30219-4

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial

C. Male^*, A.W.A. Lensing, J.S. Palumbo, R. Kumar, I. Nurmeev, K. Hege, D. Bonnet, P. Connor, H.L. Hooimeijer, M. Torres, A.K.C. Chan, G. Kenet, S. Holzhauer, A. Santamaria, P. Amedro, E. Chalmers, P. Simioni, R.V. Bhat, D.L. Yee, O. LvovaJ. Beyer-Westendorf, T.T. Biss, I. Martinelli, P. Saracco, M. Peters, K. Kallay, C.A. Gauger, M.P. Massicotte, G. Young, A.F. Pap, M. Majumder, W.T. Smith, J.F. Heubach, S.D. Berkowitz, K. Thelen, D. Kubitza, M. Crowther, M.H. Prins, P. Monagle, EINSTEIN-Jr Phase 3 Investigators

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

70 Citations (Web of Science)

Original language	English
Pages (from-to)	E18-E27
Number of pages	10
Journal	The Lancet Haematology
Volume	7
Issue number	1
DOIs	https://doi.org/10.1016/S2352-3026(19)30219-4
Publication status	Published - 1 Jan 2020

Keywords

definition
disease
oral rivaroxaban
thrombosis
DEFINITION
ORAL RIVAROXABAN
THROMBOSIS
DISEASE

Access to Document

10.1016/S2352-3026(19)30219-4

Cite this

Male, C., Lensing, A. W. A., Palumbo, J. S., Kumar, R., Nurmeev, I., Hege, K., Bonnet, D., Connor, P., Hooimeijer, H. L., Torres, M., Chan, A. K. C., Kenet, G., Holzhauer, S., Santamaria, A., Amedro, P., Chalmers, E., Simioni, P., Bhat, R. V., Yee, D. L., ... EINSTEIN-Jr Phase 3 Investigators (2020). Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. The Lancet Haematology , 7(1), E18-E27. https://doi.org/10.1016/S2352-3026(19)30219-4

Male, C. ; Lensing, A.W.A. ; Palumbo, J.S. ; Kumar, R. ; Nurmeev, I. ; Hege, K. ; Bonnet, D. ; Connor, P. ; Hooimeijer, H.L. ; Torres, M. ; Chan, A.K.C. ; Kenet, G. ; Holzhauer, S. ; Santamaria, A. ; Amedro, P. ; Chalmers, E. ; Simioni, P. ; Bhat, R.V. ; Yee, D.L. ; Lvova, O. ; Beyer-Westendorf, J. ; Biss, T.T. ; Martinelli, I. ; Saracco, P. ; Peters, M. ; Kallay, K. ; Gauger, C.A. ; Massicotte, M.P. ; Young, G. ; Pap, A.F. ; Majumder, M. ; Smith, W.T. ; Heubach, J.F. ; Berkowitz, S.D. ; Thelen, K. ; Kubitza, D. ; Crowther, M. ; Prins, M.H. ; Monagle, P. ; EINSTEIN-Jr Phase 3 Investigators. / Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children : a randomised, controlled, phase 3 trial. In: The Lancet Haematology . 2020 ; Vol. 7, No. 1. pp. E18-E27.

@article{55c0e18d4de64483922cd6a35e8b6dc5,

title = "Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial",

keywords = "definition, disease, oral rivaroxaban, thrombosis, DEFINITION, ORAL RIVAROXABAN, THROMBOSIS, DISEASE",

author = "C. Male and A.W.A. Lensing and J.S. Palumbo and R. Kumar and I. Nurmeev and K. Hege and D. Bonnet and P. Connor and H.L. Hooimeijer and M. Torres and A.K.C. Chan and G. Kenet and S. Holzhauer and A. Santamaria and P. Amedro and E. Chalmers and P. Simioni and R.V. Bhat and D.L. Yee and O. Lvova and J. Beyer-Westendorf and T.T. Biss and I. Martinelli and P. Saracco and M. Peters and K. Kallay and C.A. Gauger and M.P. Massicotte and G. Young and A.F. Pap and M. Majumder and W.T. Smith and J.F. Heubach and S.D. Berkowitz and K. Thelen and D. Kubitza and M. Crowther and M.H. Prins and P. Monagle and {EINSTEIN-Jr Phase 3 Investigators}",

year = "2020",

month = jan,

day = "1",

doi = "10.1016/S2352-3026(19)30219-4",

language = "English",

volume = "7",

pages = "E18--E27",

journal = "The Lancet Haematology ",

issn = "2352-3026",

publisher = "ELSEVIER SCI LTD",

number = "1",

}

Male, C, Lensing, AWA, Palumbo, JS, Kumar, R, Nurmeev, I, Hege, K, Bonnet, D, Connor, P, Hooimeijer, HL, Torres, M, Chan, AKC, Kenet, G, Holzhauer, S, Santamaria, A, Amedro, P, Chalmers, E, Simioni, P, Bhat, RV, Yee, DL, Lvova, O, Beyer-Westendorf, J, Biss, TT, Martinelli, I, Saracco, P, Peters, M, Kallay, K, Gauger, CA, Massicotte, MP, Young, G, Pap, AF, Majumder, M, Smith, WT, Heubach, JF, Berkowitz, SD, Thelen, K, Kubitza, D, Crowther, M, Prins, MH, Monagle, P & EINSTEIN-Jr Phase 3 Investigators 2020, 'Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial', The Lancet Haematology , vol. 7, no. 1, pp. E18-E27. https://doi.org/10.1016/S2352-3026(19)30219-4

Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children : a randomised, controlled, phase 3 trial. / Male, C.; Lensing, A.W.A.; Palumbo, J.S.; Kumar, R.; Nurmeev, I.; Hege, K.; Bonnet, D.; Connor, P.; Hooimeijer, H.L.; Torres, M.; Chan, A.K.C.; Kenet, G.; Holzhauer, S.; Santamaria, A.; Amedro, P.; Chalmers, E.; Simioni, P.; Bhat, R.V.; Yee, D.L.; Lvova, O.; Beyer-Westendorf, J.; Biss, T.T.; Martinelli, I.; Saracco, P.; Peters, M.; Kallay, K.; Gauger, C.A.; Massicotte, M.P.; Young, G.; Pap, A.F.; Majumder, M.; Smith, W.T.; Heubach, J.F.; Berkowitz, S.D.; Thelen, K.; Kubitza, D.; Crowther, M.; Prins, M.H.; Monagle, P.; EINSTEIN-Jr Phase 3 Investigators.

In: The Lancet Haematology , Vol. 7, No. 1, 01.01.2020, p. E18-E27.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children

T2 - a randomised, controlled, phase 3 trial

AU - Male, C.

AU - Lensing, A.W.A.

AU - Palumbo, J.S.

AU - Kumar, R.

AU - Nurmeev, I.

AU - Hege, K.

AU - Bonnet, D.

AU - Connor, P.

AU - Hooimeijer, H.L.

AU - Torres, M.

AU - Chan, A.K.C.

AU - Kenet, G.

AU - Holzhauer, S.

AU - Santamaria, A.

AU - Amedro, P.

AU - Chalmers, E.

AU - Simioni, P.

AU - Bhat, R.V.

AU - Yee, D.L.

AU - Lvova, O.

AU - Beyer-Westendorf, J.

AU - Biss, T.T.

AU - Martinelli, I.

AU - Saracco, P.

AU - Peters, M.

AU - Kallay, K.

AU - Gauger, C.A.

AU - Massicotte, M.P.

AU - Young, G.

AU - Pap, A.F.

AU - Majumder, M.

AU - Smith, W.T.

AU - Heubach, J.F.

AU - Berkowitz, S.D.

AU - Thelen, K.

AU - Kubitza, D.

AU - Crowther, M.

AU - Prins, M.H.

AU - Monagle, P.

AU - EINSTEIN-Jr Phase 3 Investigators

PY - 2020/1/1

Y1 - 2020/1/1

KW - definition

KW - disease

KW - oral rivaroxaban

KW - thrombosis

KW - DEFINITION

KW - ORAL RIVAROXABAN

KW - THROMBOSIS

KW - DISEASE

U2 - 10.1016/S2352-3026(19)30219-4

DO - 10.1016/S2352-3026(19)30219-4

M3 - Article

VL - 7

SP - E18-E27

JO - The Lancet Haematology

JF - The Lancet Haematology

SN - 2352-3026

IS - 1

ER -